Grant opportunity
WHO HIV Drug Resistance Call
Call to enhance evidence on HIV drug resistance.
- Funder
- World Health Organization
- 25 Jun 2026 intent; 30 Jun 2026 full submission
- 25 Jun 2026 intent; 30 Jun 2026 full submission
- Award
- See official call for award details
- Applicant
- Organizations and Institutions
- Discipline
- Health and Biomedical Sciences
- Region
- Global
- Posted
- Jun 2, 2026
Call summary
Overview
Call to enhance evidence on HIV drug resistance.
Who can apply
Research institutions and public health partners
What it supports
- Global health; HIV; Drug resistance
- Global
- Open/announced late May; active early June
Funding and duration
- See official call for award details
25 Jun 2026 intent; 30 Jun 2026 full submission
25 Jun 2026 intent; 30 Jun 2026 full submission
How to apply
Use the official source page for application instructions, required documents, eligibility rules, and final submission deadlines.
Call details
Source-based overview
Call to enhance evidence on HIV drug resistance. Official WHO portal Official source: https://www.who.int/
Eligibility
Research institutions and public health partners
Funding and benefits
See official call for award details
Themes and supported activities
Global health; HIV; Drug resistance
Global
Open/announced late May; active early June
Deadline and timeline
25 Jun 2026 intent; 30 Jun 2026 full submission: 25 Jun 2026 intent; 30 Jun 2026 full submission.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Use the official source page for application instructions, required documents, eligibility rules, and final submission deadlines.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.